Nephrotic Syndrome Clinical Trials Nephrotic Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
Condition:   Nephrotic Syndrome Interventions:   Drug: Rituximab Biosimilar ABP 798;   Drug: Daratumumab Sponsor:   Istituto Giannina Gaslini Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials